203 related articles for article (PubMed ID: 7805700)
1. Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man.
Woodcock BG; Acerbi D; Merz PG; Rietbrock S; Rietbrock N
Eur J Rheumatol Inflamm; 1993; 12(4):12-28. PubMed ID: 7805700
[TBL] [Abstract][Full Text] [Related]
2. Supermolecular inclusion of piroxicam with beta-cyclodextrin: a review of its pharmacological properties in laboratory animals.
Lister RE; Acerbi D; Cadel S
Eur J Rheumatol Inflamm; 1993; 12(4):6-11. PubMed ID: 7805705
[TBL] [Abstract][Full Text] [Related]
3. Comparative population pharmacokinetic-pharmacodynamic analysis for piroxicam-beta-cyclodextrin and piroxicam.
Wang D; Miller R; Zheng J; Hu C
J Clin Pharmacol; 2000 Nov; 40(11):1257-66. PubMed ID: 11075311
[TBL] [Abstract][Full Text] [Related]
4. Oral bioavailability of CHF1194, an inclusion complex of piroxicam and beta-cyclodextrin, in healthy subjects under single dose and steady-state conditions.
Deroubaix X; Stockis A; Allemon AM; Lebacq E; Acerbi D; Ventura P
Eur J Clin Pharmacol; 1995; 47(6):531-6. PubMed ID: 7768257
[TBL] [Abstract][Full Text] [Related]
5. Macrocyclic molecules and their pharmacological applications.
Lasagna L
Eur J Rheumatol Inflamm; 1993; 12(4):3-5. PubMed ID: 7805702
[No Abstract] [Full Text] [Related]
6. Evaluation of piroxicam-beta-cyclodextrin, piroxicam, paracetamol and placebo in post-operative oral surgery pain.
Dolci G; Ripari M; Pacifici L; Umile A
Int J Clin Pharmacol Res; 1994; 14(5-6):185-91. PubMed ID: 7672875
[TBL] [Abstract][Full Text] [Related]
7. Effects of piroxicam-beta-cyclodextrin on the gastrointestinal tract.
Warrington S
Eur J Rheumatol Inflamm; 1993; 12(4):29-37. PubMed ID: 7805701
[TBL] [Abstract][Full Text] [Related]
8. Effects of piroxicam-beta-cyclodextrin sachets on abnormal postural sway in patients with chronic low back pain.
Chang ST; Chen LC; Chang CC; Chu HY; Tsai KC
J Clin Pharm Ther; 2008 Oct; 33(5):495-506. PubMed ID: 18834364
[TBL] [Abstract][Full Text] [Related]
9. Piroxicam-beta-cyclodextrin: effects on gastrointestinal blood loss and gastric mucosal appearance in healthy men.
Warrington S; Debbas N; Farthing M; Horton M; Umile A
Int J Tissue React; 1991; 13(5):243-8. PubMed ID: 1806546
[TBL] [Abstract][Full Text] [Related]
10. Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease.
Reginster JY; Franchimont P
Eur J Rheumatol Inflamm; 1993; 12(4):38-46. PubMed ID: 7805703
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic profiles of two tablet formulations of piroxicam.
Rasetti-Escargueil C; Grangé V
Int J Pharm; 2005 May; 295(1-2):129-34. PubMed ID: 15847998
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic profile of piroxicam beta-cyclodextrin, in rat plasma and lymph.
Kimura E; Bersani-Amado CA; Sudo LS; Santos SR; Oga S
Gen Pharmacol; 1997 May; 28(5):695-8. PubMed ID: 9184804
[TBL] [Abstract][Full Text] [Related]
13. Piroxicam concentrations in plasma and synovial fluid after a single dose of piroxicam-beta-cyclodextrin.
Bannwart B; Bertin P; Péhourcq F; Schaeverbeke T; Gillet P; Lefrançois G; Trèves R; Dehais J; Netter P; Gaucher A
Int J Clin Pharmacol Ther; 2001 Jan; 39(1):33-6. PubMed ID: 11204935
[TBL] [Abstract][Full Text] [Related]
14. Influence of cyclodextrin complexation on piroxicam gel formulations.
Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
[TBL] [Abstract][Full Text] [Related]
15. Raman and solid state 13C-NMR investigation of the structure of the 1 : 1 amorphous piroxicam : beta-cyclodextrin inclusion compound.
Redenti E; Zanol M; Ventura P; Fronza G; Comotti A; Taddei P; Bertoluzza A
Biospectroscopy; 1999; 5(4):243-51. PubMed ID: 10478955
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic study on piroxicam at the steady-state in elderly subjects and younger adults after administration of piroxicam beta-cyclodextrin.
Acerbi D; Bonati C; Boscarino G; Bufalino L; Cesari F; D'Ambrosio E; Mansanti P; Scali G
Int J Clin Pharmacol Res; 1988; 8(3):175-80. PubMed ID: 3403105
[TBL] [Abstract][Full Text] [Related]
17. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic profile of droxicam.
Martínez L; Sánchez J
Eur J Rheumatol Inflamm; 1991; 11(4):10-4. PubMed ID: 1365484
[TBL] [Abstract][Full Text] [Related]
19. Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states.
Lee CR; Balfour JA
Drugs; 1994 Dec; 48(6):907-29. PubMed ID: 7533698
[TBL] [Abstract][Full Text] [Related]
20. Beta- cyclodextrin complexation improves absorption and gastric tolerability of piroxicam.
Cadel S; Bongrani S
Acta Physiol Hung; 1990; 75 Suppl():45-6. PubMed ID: 2371898
[No Abstract] [Full Text] [Related]
[Next] [New Search]
